Internal Medicine, Cooper University Health Care, Camden, New Jersey, USA
Internal Medicine, Cooper University Health Care, Camden, New Jersey, USA.
BMJ Case Rep. 2021 Jan 28;14(1):e238733. doi: 10.1136/bcr-2020-238733.
We present a case of a 38-year-old man with a history of chronic thromboembolic pulmonary hypertension on therapeutic anticoagulation and recent hospitalisation for COVID-19 disease who was hospitalised for recurrent acute pulmonary embolism despite therapeutic anticoagulation with warfarin (International Normalized Ratio (INR) of 3.0). Our case highlights the hypercoagulable state associated with COVID-19 disease and the absence of standardised approaches to anticoagulation treatment for this population.
我们报告了 1 例 38 岁男性患者,该患者患有慢性血栓栓塞性肺动脉高压,正在接受抗凝治疗,近期因 COVID-19 住院,尽管华法林(国际标准化比值(INR)为 3.0)进行了治疗性抗凝治疗,但仍反复发作急性肺栓塞。我们的病例突出了 COVID-19 疾病相关的高凝状态,以及缺乏针对该人群的抗凝治疗标准方法。